Risperdal Lawsuit Settles Three Days Before Trial
- Last Updated: August 13th, 2023
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Risperdal Lawsuit Settles Three Days Before Trial
Johnson & Johnson settled the seventh Risperdal case scheduled to go before a jury in Philadelphia’s mass tort program on January 6, just three days before the trial was to begin.
The latest lawsuit involved a New York man who alleged that he developed gynecomastia as a result of taking the antipsychotic medication Risperdal.
The plaintiff was prescribed the drug “off-label,” meaning for a use that was not approved by the U.S. Food and Drug Administration (FDA), and took it from 2002 until 2011.
The FDA did not approve Risperdal for use in children and adolescents until 2006.
Table of Contents
What is Gynecomastia?
Gynecomastia is a condition in which boys and men develop tender and swollen breasts.
Surgery is often required to correct the condition, although liposuction can be effective in removing excess breast tissue in mild to moderate cases.
In more severe cases, patients may need a mastectomy to remove breast tissue and excess breast skin.
A 2014 study presented at an annual meeting of the American Association for Geriatric Psychiatry concluded that users of Risperdal might face as much as a 69 percent increased risk of gynecomastia compared to those who have not taken the medication.
Because of the study’s results, researchers suggested that doctors prescribe Zyprexa or Seroquel to males instead of Risperdal to reduce the chances of developing gynecomastia and other harmful conditions and side effects.
Risperdal Litigation Timeline
Johnson and Johnson has maintained a busy litigation schedule related to its antipsychotic medication for over a year:
- In the first Philadelphia Risperdal trial, a jury awarded the plaintiff $2.5 million in February 2015.
- The second Risperdal trial returned a verdict in favor of Janssen, although the jury determined that the Risperdal labeling did not provide adequate warnings about the drug’s potential risks.
- The third and fourth Risperdal trials returned verdicts of $1.75 million (later reduced to $680,000) and $500,000 for plaintiffs.
- The fifth Risperdal case ended with a $70 million verdict in favor of the plaintiff, later increased by more than $6 million.
- The sixth case, now on appeal, was dismissed before trial in late October after the judge granted Janssen’s motion for summary judgment.
Two more Risperdal cases are scheduled for trial on February 21, according to the Philadelphia Court of Common Pleas Trial Division.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
